Navigation Links
Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics
Date:3/12/2008

MADISON, N.J., March 12 /PRNewswire-FirstCall/ -- The percentage of positive tests for methamphetamine among U.S. job applicants and workers in the general U.S. workforce dropped more than 22 percent between 2006 and 2007. These findings, from the Quest Diagnostics Drug Testing Index(R), reflect the reversal of an upward trend in use of the drug by more than 73 percent from 2002 to 2004. These data were released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of employment-related drug testing services. The report also shows that positive tests for cocaine in the general U.S. workforce were down 19 percent between 2006 and 2007 and that overall drug use, among workers subject to drug testing, remains at an all-time low.

Methamphetamine, the most commonly abused type of amphetamine, increased in production and trafficking during the 1990's to become the most prevalent illegally manufactured synthetic drug in the United States. Analysis of the Quest Diagnostics Drug Testing Index, released semi-annually, suggests that efforts to reduce illicit, clandestine production of methamphetamine may be having an impact on workplace positive tests for the drug.

"The fact that America's workers are using cocaine and methamphetamine at some of the lowest levels in years is further evidence of the tremendous success that law enforcement is having at impacting the nation's illicit drug supply," said DEA Acting Administrator Michele M. Leonhart. "DEA will continue its relentless assault on the drug supply to help keep these dangerous drugs out of our neighborhoods."

While the 2007 Quest Diagnostics Drug Testing Index shows that positive methamphetamine tests have decreased, it also indicates that the u
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment
2. Partnership for a Drug-Free America and Council Bluffs Police Department Introduce Methamphetamine Prevention Program to Iowa Law Enforcement
3. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
4. Methamphetamine study suggests increased risk for HIV transmission
5. Following School Suicide, National Childrens Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth
6. Neurologic & Orthopedic Hospital of Chicago Ranked Among Top in Nation for Spine Surgery
7. New study sheds light on excessive drinking among the elderly
8. Depression Raised Risk of Subsequent Pregnancies Among Black Teen Moms
9. NIH-funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors
10. Mayo Researchers Look for Explanation Behind High Incidence of Diabetes Among Asian Indians
11. Mayo researchers look for explanation behind high incidence of diabetes among Asian Indians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ceuticals' top-selling Adderall XR drug for attent... carry stronger warnings about the risk of side ef...d the drug company to make clear to the public abo... such as hallucinations and paranoia. This can oc...
...an Children’s Hospital was caught in the throes of...tioning, asunder! On March 13th, around 10:30 pm, ...’s relative. // The relative wielded a gun in his ... was on the road to recovery, not be shifted from ...
...pur there is an outbreak of the hand, foot and mou...st their lives in Sarawak state//. Hence to calm d...out a series of preventive measures. It was said t... five areas of the state, bringing the total numbe...
...ctors at a Florida Boot Camp beat a black teenager...ere captured// by a surveillance camera. Initiall...natural death, but upon a second postmortem, the s...n Anderson all of 14, had been brutally beaten to ...
Other Medicine News:Health News:Malaysia to Beef in Medical Care to Fight against HFMD 2
(Date:8/19/2008)...RNewswire/ -- Addrenex Pharmaceuticals (, http://w...this month to,further its goal of identifying and ... over the next 18 months., The fast-paced timelin...pany,s recent successes in developing two new drug... disorder and CloniBID for hypertension,over the ...
(Date:8/19/2008)...wswire-FirstCall/ -- Vical Incorporated,(Nasdaq: ...th the Karolinska,Institutet (KI), a leading Europ...for Infectious Disease Control (SMI), a government... adjuvant with the Biojector(R),2000 needle-free i...,OTCBB: BJCT) for a multivalent preventive DNA va...
(Date:8/19/2008)...9 /- VION,PHARMACEUTICALS, ...ad,entered into an agreement with the Dutch-Belgia...(the "HOVON") to conduct a clinical trial of,larom...remission-induction,therapy in patients aged 18-65...mia (AML) and high-risk myelodysplasia (MDS)., Al...
(Date:8/18/2008)... /PRNewswire-USNewswire/ -- Due to an,exceptionall...es in,southeastern Pennsylvania, the Department of...will be stepping up efforts this week to combat th...kely to carry -- the virus., While only one human...is year (a 27-year-old Montgomery County woman), D...
Breaking Medicine Technology:Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Plan expedites alternatives to animal testing 11052 1Plan expedites alternatives to animal testing 11052 2Plan expedites alternatives to animal testing 11052 3Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 1Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 2Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 3Governor Rendell Says 2008 09 Budget Renews Commitment to Vulnerable Pennsylvanians 11050 4Stacy DeFoe Earns Certified Association Executive Credential 11049 1Stacy DeFoe Earns Certified Association Executive Credential 11049 2Vestergaard Frandsen to Launch High Tech Filter to Provide Clean and Safe Drinking Water to People in Developing Nations 11047 1
...ed 41 to 50% of Patients and Was,Well-Tolerated ,P... News Network),-- Barrier Therapeutics, Inc. (NASD...and markets dermatology products, today,announced ...ozole,in lamellar ichthyosis, a rare genetic disor...h is characterized by a thick,scaling of the skin ...
... 14, 2007 /PRNewswire/ -- PARI Pharma will,present...ing drug,delivery system as well as lung depositio...haled liposomal Ciclosporin A formulation in,lung ...s Conference,(ECFC) in Belek, Turkey this week. , ...vanced,inhalation delivery platforms, PARI has cre...
Other Medicine Technology:Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 2Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 3Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 4Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis 5PARI Pharma Presents Study Results of Sinus Delivery and Inhaled,Liposomal Ciclosporin A at European Cystic Fibrosis Conference 2
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes.
Inquire
Finntip Filters are ideal for PCR and other amplification methods, or for any work where aerosol contamination might occur. They are designed for pipetting DNA/RNA solutions, infectious materials, la
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote
Medicine Products: